收费全文 | 2937篇 |
免费 | 202篇 |
国内免费 | 23篇 |
耳鼻咽喉 | 42篇 |
儿科学 | 75篇 |
妇产科学 | 41篇 |
基础医学 | 444篇 |
口腔科学 | 241篇 |
临床医学 | 262篇 |
内科学 | 590篇 |
皮肤病学 | 73篇 |
神经病学 | 298篇 |
特种医学 | 47篇 |
外科学 | 271篇 |
综合类 | 11篇 |
预防医学 | 343篇 |
眼科学 | 46篇 |
药学 | 213篇 |
中国医学 | 25篇 |
肿瘤学 | 140篇 |
2024年 | 4篇 |
2023年 | 55篇 |
2022年 | 97篇 |
2021年 | 129篇 |
2020年 | 95篇 |
2019年 | 135篇 |
2018年 | 152篇 |
2017年 | 102篇 |
2016年 | 113篇 |
2015年 | 160篇 |
2014年 | 186篇 |
2013年 | 201篇 |
2012年 | 287篇 |
2011年 | 310篇 |
2010年 | 163篇 |
2009年 | 123篇 |
2008年 | 161篇 |
2007年 | 154篇 |
2006年 | 133篇 |
2005年 | 98篇 |
2004年 | 78篇 |
2003年 | 78篇 |
2002年 | 70篇 |
2001年 | 4篇 |
1999年 | 6篇 |
1998年 | 6篇 |
1997年 | 7篇 |
1996年 | 7篇 |
1995年 | 4篇 |
1994年 | 5篇 |
1993年 | 5篇 |
1991年 | 1篇 |
1990年 | 2篇 |
1989年 | 3篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 3篇 |
1983年 | 2篇 |
1982年 | 1篇 |
1980年 | 1篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1973年 | 2篇 |
1971年 | 1篇 |
1968年 | 1篇 |
1964年 | 1篇 |
1957年 | 1篇 |
1955年 | 1篇 |
1924年 | 1篇 |
Evidence-based policy measures need non-interest-guided information about the health status of a population and the diseases that affect the population the most. In such cases, a national burden of disease study can provide reliable insights at the regional level.
AimThis article presents the potential of the BURDEN 2020 project and its expected outcome for Germany at the national and regional level.
MethodsThe BURDEN 2020 project uses several indicators including years of life lost (YLL) to cover the impact of mortality and years lived with disability (YLD) to cover morbidity. The sum of both is the measure of population health called disability adjusted life years (DALY).
ResultsThe study ranks individual diseases and risk factors based on their impact on population health. The burden of disease approach is assumed to be sensitive to subnational differences and may generate immediate benefits for regional planning. The BURDEN 2020 study will pilot a national burden of disease study for Germany that will later be transformed into a continuous data processing and visualization tool. This is done by using, modifying and supplementing the methodology employed by the Global Burden of Disease (GBD) study to better fit the needs of health policy in Germany. This study is aimed at calculating the disease burden for up to 17 preselected diseases. Furthermore, the estimates of burden of disease are attributed to a selected set of risk factors.
ConclusionThe Burden 2020 study will provide the results of a new, health-related data processing system to the public. This includes a noninterest-guided presentation of the burden of disease (DALY) in Germany at the national and regional level.
相似文献Background
Colonoscopy is the most frequent exam used to evaluate colonic mucosa, allowing the diagnosis and treatment of many diseases. The appropriate bowel preparation is indispensable for the realization of colonoscopy. Therefore, it is necessary the use of laxative medications, preferentially by oral administration.Aim
To compare two medications used in bowel preparation in adult patients going to ambulatory colonoscopy and to analyze the patients'' profile.Methods
A double-blind prospective study with 200 patients, randomized in two groups: one that received polyethilene glycol and another that received lactulose. The patients answered to questionnaires to data compilation, as tolerance, symptoms and complications related to preparation. Besides, it was also evaluated the prepare efficacy related to the presence of fecal residue.Results
Intestinal habit alterations and abdominal pain were the main reasons to realize the exams and hypertension was the most prevalent comorbidity. Ten percent of the ones who received lactulose didn''t get to finish the preparation and 50% considered the taste "bad, but tolerable". The most common subjective symptom after the medication was nausea, especially after lactulose. During the exam, most of the patients who used lactulose had a "light discomfort" and the ones who used polyethilene glycol considered the discomfort as "tolerable". The quality of the preparation was good in 75%, undependable of the medication that was used.Conclusion
Polyethilene glycol was more tolerable when compared to lactulose, without difference on the quality of the preparation. 相似文献To evaluate the potential of conventional glass ionomer cement (GIC), Biodentine™, MTA, and Portland cement to induce mineral density changes in carious dentin compared to zinc oxide eugenol control cement (ZOE).
Materials and methodsFifty blocks of bovine root dentin were prepared and a biofilm model using ATCC strains of S.mutans, S.sobrinus, and L.casei was used to promote artificial dentin lesions. After demineralization, the blocks were randomly divided into the five cement groups. Half of the surface of each specimen received the tested material and the other half was covered with wax (control). Samples were stored in phosphate buffered saline solution for 30 days and after that were scanned in a micro-CT with standardized parameters. Dentin mineral density changes were calculated using differences in plot profiles of the exposed and control carious dentin. Friedman’s test, followed by Wilcoxon signed-rank test was used with 5% significance.
ResultsMean ΔZ values for the cements were 48.63 ± 19.09 for the control (ZOE), 63.31 ± 32.59 for Biodentine™, 114.63 ± 72.92 for GIC, 109.56 ± 66.28 for MTA, and 106.88 ± 66.02 for Portland cement. All cements showed a statistically significant increase in ΔZ values compared to the control, but Biodentine™ values were statistically significantly lower compared to GIC and the other calcium silicate cements.
ConclusionsTested materials present potential to induce mineral density changes in carious bovine dentin. MTA, Portland, and GIC showed higher bioactivity potential than Biodentine™.
Clinical relevanceBased on minimally invasive concept, materials with remineralization potential can be used to preserve diseased but still repairable dental tissue.
相似文献